Keith P. Klugman, MB BCh, PhD, FAAM, FIDSA
William H. Foege Chair of Global Health
Hubert Department of Global Health
Rollins School of Public Health
Professor of Medicine
Division of Infectious Diseases
Emory University School of Medicine
Atlanta, Georgia


Keith P. Klugman, MB BCh, PhD, is the William H. Foege Chair of Global Health in the Hubert Department of Global Health at the Rollins School of Public Health, Emory University in Atlanta, Georgia. Dr. Klugman is Professor of Medicine, Division of Infectious Diseases, School of Medicine, Emory University. He is also a Visiting Researcher within the Respiratory Pathogens Branch at the Centers for Disease Control in Atlanta. Dr. Klugman's primary research interests include antibiotics, antimicrobial resistance and vaccines for bacterial pathogens; particularly the pneumococcus.

Dr. Klugman earned his bachelor's degree in Anatomy with an Honor's degree in Physiology at University of Witwatersrand, Johannesburg, South Africa. He received his medical degree and PhD in Physiology at University of Witwatersrand. Dr. Klugman continued his postdoctoral training at University of Witwatersrand as a resident in Medical Microbiology and research fellow on the Medical Research Council (MRC). He served as a Charles H. Revson research fellow and subsequently as an adjunct faculty member until 2000 at The Rockefeller University in New York.

A Fellow of the American Academy of Microbiology and the Infectious Diseases Society of America, Dr. Klugman is highly regarded within the infectious disease community. Since 1999, he has served on the Working Group of Pneumonia Vaccines for the World Health Organization. He currently chairs the International Board of the American Society for Microbiology and the US National Committee for the International Union of Microbiological Studies. Dr. Klugman's extensive recognition includes the Emanuel Wolinsky Award (co-recipient) granted by the Infectious Diseases Society of America for Author of the Best Article Published in Clinical Infectious Diseases in 2003, and the 2004 Honor Award for Distinguished Service from the US Department of Health and Human Services. He is author of over 350 articles to date and is principal investigator for several funded studies focused on pneumococcal pneumonia and associated vaccines.